|Articles|August 2, 2012
- Pharmaceutical Technology-08-02-2012
- Volume 36
- Issue 8
Pharmaceutical Technology, August 2012 Issue (PDF)
Measuring Growth - Big Pharma's Manufacturing Investments
Advertisement
Articles in this issue
about 14 years ago
Q&A with Babu Padmanabhan, STEER Engineeringabout 14 years ago
The Truth About Drug Shortagesabout 14 years ago
Report from Japanabout 14 years ago
Pharmaceutical-Based Cargo Security and Theft Preventionabout 14 years ago
Scaling up API Synthesesabout 14 years ago
Small Changes, System-Wide Impactabout 14 years ago
Measuring Growth in Big Pharma's Manufacturing Investmentabout 14 years ago
Gauging Biopharm Outsourcingabout 14 years ago
In the Spotlight August 2012about 14 years ago
FDA User-Fee Legislation Sets Stage for ChangeAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
What Does TAUKLARIFY's Approval Mean for Alzheimer's Drug Developers?
2
Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.
3
Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem
4
Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?
5